<p>Vasospastic angina (VSA) is a type of chest pain that begins at rest and is caused by a spasm of the coronary arteries. Short-acting nitrates may help reduce pain in the refractory. Reportedly, vasospastic angina (VSA) is often misdiagnosed because of the lack of promptitude testing. One typical sign of coronary artery disease is VSA. It may cause angina pectoris, go undetected, or cause heart attack and potentially fatal arrhythmias. Most patients with VSA benefit from effective symptom relief with vasodilators, but the overall prognosis of these patients is not satisfactory, which means that the underlying prognostic variables and pathogenic pathways are unknown. Individuals with severe or persistent VSA are also more likely to die suddenly during episodes of ischemic events or develop life-threatening arrhythmias, as established treatments are usually ineffective. Notably, Inflammatory findings form a significant but variable component in these acute ischemic events, and there is evidence that immunomodulatory agents such as glucocorticoids and immunoglobulins may help to achieve remission in these patients. Inflammatory cytokines are excellent diagnostic indicators; according to current research, inflammation is a key factor in the development and course of coronary spasms. In addition to exploring the previously unknown associations between inflammation, myocarditis and vasospasm, this systematic review provides a comprehensive overview of vasospasm in terms of clinical and theoretical features. And also aims to enhance the comprehension of the cause, diagnosis and treatment of VSA by revealing this complex relationship and ultimately providing new insights into this challenging disease.</p>